Purpose of review Advances in the field of monocyte and macrophage biology have dramatically changed our understanding of their role during homeostasis and inflammation. Here we review the role of these important innate immune effectors in the lung during inflammatory challenges including lung transplantation.
INTRODUCTION
Monocytes and macrophages are members of the mononuclear phagocyte system, a component of innate immunity. Monocytes are bone marrowderived leukocytes that circulate in the blood and spleen. They are characterized by their ability to recognize 'danger signals' via pattern recognition receptors. Monocytes can phagocytose and present antigens, secrete chemokines, and proliferate in response to infection and injury. Once recruited to tissues, monocytes are capable of differentiating into macrophages and dendritic cells. Macrophages, conversely, are generally considered terminally differentiated cells that phagocytose pathogens or toxins, secrete chemokines to recruit other immune cells, and migrate to local lymph node beds via lymphatics where they present processed antigens. Here we will discuss the current understanding of monocyte and macrophage function in lung immunobiology based on animal and human studies. We will review their role in homeostasis and response to lung infection and tissue injury. Additionally, we will review their importance in lung transplantation with a focus on ischemiareperfusion injury, primary graft dysfunction, and allograft rejection.
MONOCYTES AND MACROPHAGES IN LUNG HOMEOSTASIS
Although once thought of as a lineage of cells with macrophages as the terminally differentiated cell in a progression from monocyte to macrophage, studies over the past 20 years have proven otherwise. Advances in our understanding of monocyte and macrophage biology have direct applications to the lung and maintenance of its homeostasis. Together,
MONOCYTES
Much of our knowledge about monocytes comes from studies using mouse tissues and human blood. In both humans and mice, monocytes can be subdivided into: classical inflammatory monocytes that are Ly6C 
Classical monocytes
Classical monocytes are well characterized. In response to infection or injury, they proliferate in the bone marrow, are released into circulation in a CCR2-dependent manner and home to the site of interest via a chemokine gradient [3] . During bacterial infection, for example, these monocytes home to the site of infection and phagocytose pathogens, secrete a distinct set of chemokines that lead to recruitment of other immune cells, and present antigen via class II MHC [4] . Murine studies have also revealed that these monocytes can exit the vasculature, and without further differentiating, survey the tissue microenvironment, before departing via the lymphatics [5] . The spleen functions as a reservoir for monocytes. In response to signals emanating from a distant tissue injury, for instance release of angiotensin II during myocardial infarction, these cells can be mobilized to the site of injury from the spleen [6] .
In the lung, these cells are capable of differentiating into pulmonary dendritic cells and macrophages. Utilizing a combination of fate-mapping techniques, parabionts, and fluorescent reporter murine studies, investigators have shown that Ly6C high classical monocytes differentiate into both the CD11b þ CD103 À and CD11b À CD103 þ dendritic cell subsets [7] . In addition, these cells differentiate into macrophages when recruited to the lung and help replenish the tissue-resident macrophage pool when depleted either by injury or through experimental manipulation [8] .
Nonclassical and intermediate monocytes
Nonclassical endothelial patrolling monocytes were first reported in 2007 [9] and studies of their biology and function remain ongoing. These cells are likely the descendants of classical monocytes that have returned to the bone marrow and under the control of Nur77 (Nr4a1) mature into nonclassical monocytes [10] . They display a distinct motility and crawling pattern. In-vivo imaging studies have shown nonclassical monocytes crawling along the luminal side of the endothelium. This integrindependent crawling is independent of the direction of blood flow. In fact, it is frequently against the direction of flow [11 & ,12] . In the lung, nonclassical monocytes are capable of differentiating into CD11b þ CD103 À dendritic cells [7] . Recent studies have further attempted to explore the role of these monocytes. Investigators have shown that nonclassical monocytes are involved in intraluminal surveillance of the endothelium and phagocytosis of injured endothelial cells along with recruitment of neutrophils to the site of injury [13] . In addition, these cells have also been shown to limit tumor metastases to the lung via the CX3CR1-CX3CL1 axis [14] . Studies of human nonclassical monocytes have shown that these monocytes sense nucleic acids and viruses via Toll-like receptor 7 (TLR7) signaling and can initiate the innate immune response by secreting cytokines [15] . These monocytes can be mobilized from the marginalized vascular compartment during vigorous exercise, sepsis, and after cardiac surgery [16] [17] [18] and are depleted by high-dose glucocorticoid treatment [19, 20] .
However, there are conflicting reports regarding the function of nonclassical monocytes. Some studies suggest this population secretes proinflammatory cytokines, whereas others suggest they are antiinflammatory and promote the resolution of inflammation and the initiation of healing and fibrosis [14] . Difficulty differentiating nonclassical monocytes from intermediate monocytes by cell surface marker expression may account for the conflicting
KEY POINTS
Monocytes and macrophages in the lung are crucial players in host innate immune defense against pathogens.
Processes of sterile inflammation involved in lung transplantation, including mechanical ventilation, ischemia-reperfusion, and primary graft dysfunction have been shown to be monocyte and macrophage dependent.
Further studies are needed to elucidate the role of monocytes and macrophages in the pathogenesis of primary graft dysfunction and lung allograft rejection.
reports regarding the function of these cells. In fact, as nonclassical monocytes have become the subject of more intense investigation, it has become clear that there is a population of 'intermediate' monocytes. Murine Ly6C and human CD14 þ are expressed in monocytes at high, intermediate, and low levels as a continuum, and intermediate levels of these surface markers along with expression of the cell surface marker 6-sulfo LacNac (slan) identify the intermediate monocyte subset. When studied as distinct populations, intermediate monocytes show higher expression of MHCII and are more closely related to classical than nonclassical monocytes based on transcriptome analyses [21, 22] .
MACROPHAGES
Macrophages exist in tissues as sentinels, sensing pathogens and injury. Although once thought of as being constantly replenished by circulating monocytes, murine studies over the past decade have revealed tissue-resident macrophages to be capable of self-renewal. These include Kupffer cells in the liver, red pulp macrophages in the spleen, Langerhans cells in the skin, cardiac-resident macrophages, and alveolar macrophages in the lung [23, 24] .
Cardiac-resident and lung-resident macrophages have marked heterogeneity. A recent study identified distinct populations of cardiac macrophages, some of which were capable of self-renewal, and others which were replenished by circulating monocytes [25] . Similarly, in the lung, alveolar macrophages and lung-resident interstitial macrophages appear to be distinct populations with independent lineages [26 & ]. These populations, while heterogeneous, appear capable of carrying out the functions traditionally considered to be of macrophages, including phagocytosis of pathogen, efferocytosis of injured host cells, secretion of cytokines upon activation, and migration via lymphatics to present antigen, initiating the adaptive immune response. Macrophage activation occurs in two distinct varieties. The first is 'classical' or 'M1' activation, which leads to a proinflammatory phenotype. In response to extra-or intracellular pathogens, M1 macrophages upregulate inducible nitric oxide synthase and secrete proinflammatory chemokines and cytokines via pattern recognition receptors. They also present antigen via class II MHC, initiating inflammation, recruitment of granulocytes, and a type-1 helper T-cell response. The second, 'alternative' or 'M2' activation is more varied in its phenotype. In response to IL-4 and IL-13 during allergy response or parasite infection, M2 macrophages secrete histamine and promote killing and encapsulation of parasites. Outside of the realm of pathogen response, M2-activated macrophages are capable of down-regulating the initial inflammatory response and promoting the resolution of inflammation and initiation of tissue healing and fibrosis [27] . Importantly, the M1/M2 classification of activation is likely too dichotomous in its characterization and the actual activation states of macrophages is probably better represented along a continuum in response to a variety of stimuli with responses ranging from proinflammatory to antiinflammatory, demonstrating the remarkable plasticity of macrophages [28, 29] .
MONOCYTE AND MACROPHAGE RESPONSES TO MECHANISMS OF HOST INJURY AFTER LUNG TRANSPLANT
Patients undergoing lung transplant are subject to a multitude of infectious and inflammatory insults. These include ischemia-reperfusion injury (IRI), mechanical ventilation, and infection by commensal and lung pathogens. Any of these insults can result in primary graft dysfunction (PGD), acute lung injury, and acute respiratory distress syndrome, depending on the cause (Fig. 1b-d) . In the worst lung injury phenotypes, regardless of cause, neutrophils infiltrate the alveolar space and neutrophil extracellular traps (NETS) are formed [30] [31] [32] [33] . When released, NETS are meant to help capture and facilitate removal of pathogens [34] . However, when the inflammatory response becomes overwhelming, NETS can become pathogenic and contribute to the cycle of atelectrauma, ineffective gas exchange across the alveolar-capillary barrier, and respiratory failure. A review of neutrophils is beyond the scope of this review. However, it is important to understand their role in inflammation, as they are frequently the effector cells recruited by monocytes and macrophages. Infiltration of the lung by neutrophils and the presence of NETS are also frequently used as signs of severe lung injury.
PATHOGEN RESPONSE
Lung transplant recipients are particularly susceptible to pathogens. Long-standing lung disease is frequently complicated by prior infections, some frequent and with repeated hospitalizations. Recurrent or incompletely treated infections, in addition to donor-acquired pathogens, immunosuppression, mechanical ventilation, and mandatory ICU stay, all place recipients at high risk of lung injury from pathogens.
Both monocytes and macrophages utilize pattern-recognition receptors to recognize pathogens and initiate their response. Classical monocytes are mobilized in response to bacterial, fungal, protozoal, and viral pathogens [35] . On arrival to inflamed or infected tissue, they differentiate into either dendritic cells or macrophages. This distinction is not clear-cut, but rather based on cytokine profile and immunophenotyping. For example, in models of mouse colitis, Ly6C high monocytes are recruited to the intestine and give rise to CX3CR1 þ dendritic cells which then phagocytose bacteria and transport them to mesenteric lymph nodes to induce T-cell response [36] . The same circulating Ly6C high monocytes are capable of differentiating into TNF-a and inducible nitric oxide producing dendritic cells (DCs) or differentiate into macrophages which, depending on environmental cues, can either contribute to a proinflammatory milieu or resolution of inflammation [37, 38] . Current guidelines recommend referring to these cells as simply 'monocyte-derived cells' or MoDCs to avoid confusion, as the functions can overlap [39] .
In another layer of complexity, nonclassical monocytes are also recruited, albeit in a less robust fashion, in the initial response to inflammation. In the initial comprehensive report of their biology, they participated in the initial inflammatory response through the secretion of tumor necrosis factor and chemokines [9] . Their response has been particularly well studied in response to circulating nucleic acids or viral infection via TLR7/8, endothelial injury via TLR7, or tumor metastasis control via CX3CR1 [14, 15] . Altogether, the studies on nonclassical monocytes portray a population that appears to be resident vascular endothelial macrophages.
Distinct from the intravascular monocyte is the resident alveolar macrophage. In the lung, alveolar macrophages serve as the 'first responders' to pathogens, particulate matter, and tissue injury. Along with alveolar epithelial cells, they comprise the mucosal barrier of the lung. As a result, alveolar macrophages have been implicated in both inflammatory and fibrotic lung states. Although depletion of alveolar macrophages has been shown to decrease lung injury, it is also associated with decreased pathogen clearance, demonstrating the crucial role for macrophages in host defense [40] .
VENTILATOR-INDUCED LUNG INJURY
As all lung transplant recipients are mechanically ventilated during the postoperative period, and some for prolonged periods of time, we review here current knowledge of the contribution of monocytes and macrophages to mechanical ventilatorinduced lung injury (VILI). VILI has been well studied in animal models. The prevailing hypothesis is that the mechanical stress inflicted on the alveolar unit causes release of damage-associated molecular patterns, which can ligate TLRs, nucleotide-binding oligomerization domain-like receptors (NLRs) and the receptor for advanced glycosylation end products. Damage-associated molecular patterns can be recognized by both alveolar macrophages and monocytes and act downstream through several effector mechanisms.
Animal studies have shown that depletion of alveolar macrophages attenuates the severity of VILI [41] . Mechanistic studies have revealed the response to be inflammasome-mediated, where the stretch injury causes NLR-containing pyrin domain 3 (NLRP3) activation and induces the release of IL-1b from alveolar macrophages [42] [43] [44] . Additional studies showed alveolar macrophage highmobility group box-1 and possibly transient receptor potential vanilloid 4 to be involved in neutrophil recruitment to the alveolar space and lung vascular permeability and lung edema [45] [46] [47] . Human studies have correlated BAL levels of NLRP3 mRNA with short periods of high tidal volume ventilation [44] .
An additional line of investigation has implicated lung-marginated monocytes in the pathophysiology of VILI. In these studies, classical monocytes were recruited to the lung during high tidal volume ventilation and depletion of these monocytes was protective against lung injury [48, 49] . In a recent study, the mechanism of transduction of stretch injury to the lung was revealed to first involve pulmonary endothelium, then alveolar epithelium, and lastly alveolar macrophages [50] . Together, these studies suggest that, in animal models, both pulmonary monocytes and macrophages mediate VILI.
ISCHEMIA-REPERFUSION INJURY AND PRIMARY GRAFT DYSFUNCTION
Ischemia-reperfusion injury is the sterile inflammation that results from the resumption of blood flow after the mandatory ischemic period during clinical lung transplantation. This total ischemia time period consists of cold ischemia, during which the organ is transported in cold storage; and warm ischemia, during which the organ is taken out of cold storage for implantation. The total ischemia for double lung transplantation is generally 6 h or less in which each lung undergoes about 1-2 h of warm ischemia. Warm ischemia has been studied using hilar clamping, during which either an isolated pulmonary artery or the entire pulmonary hilum is temporarily clamped for a time period of 30 min to 2 h [51] . This model of pulmonary IRI is associated with severe lung injury mediated by TLR and NLR inflammasome signaling. Cold ischemia and primary graft dysfunction have been studied using a murine single lung transplant model, with up to 18 h of allograft cold ischemia time prior to implantation [52] .
The majority of work to-date has focused on the role of the alveolar macrophage in IRI and PGD. Both IRI and PGD are characterized by early neutrophil infiltration of the alveolar spaces and recent studies have shown that this leads to the formation of neutrophil extracellular traps and lung injury [33] . Indeed, macrophage-induced early reperfusion injury and neutrophil recruitment has been postulated and verified by several groups using animal models of both warm and cold ischemia [53 & , [54] [55] [56] [57] , but there is some conflicting evidence as to whether depletion of alveolar macrophages is protective or injurious [58] .
However, there is also evidence that implicates the involvement of monocytes in IRI. In one study utilizing intravital multiphoton microscopy of the lung and the murine lung transplant model, monocytes and neutrophils were found surveying the lung at steady-state. Four hours after allograft implantation, dynamic clusters of neutrophils associated with monocytes which were absent when blood monocytes were depleted, suggesting a role for monocyte-mediated extravasation of neutrophils during inflammation [59] . Furthermore, our recent data show that depletion of intravascular monocytes utilizing clodronate-loaded liposomes in mice abrogates neutrophil extravasation at 24 h after single-lung transplant (manuscript under preparation). We have found that there are pulmonary intravascular monocytes that mediate transendothelial migration of neutrophils in lung allografts, leading to PGD [60] . Additionally, in a recent study of the leukocyte filter trap in an ex-vivo lung perfusion circuit, human monocytes capable of differentiating into MoDCs were identified [61] . Given the protective effect of ex-vivo lung perfusion against PGD, this finding may implicate monocytes as a critical player in the pathogenesis of PGD.
Although alveolar macrophage and epithelial cell injury and dysfunction can cause lung injury, there is a component of endothelial dysfunction that has yet to be incorporated into current understanding of primary graft dysfunction pathogenesis. The endothelial dysfunction that occurs during IRI and PGD increases expression of cell adhesion molecules necessary for arrest of monocytes and neutrophils, implicating a possible role for classical monocytes. The injured endothelium also generates injurious reactive oxygen species and nitric oxide, and as nonclassical monocytes are responsible for phagocytosis and disposal of injured or necrotic endothelial cells, their role in PGD and IRI is worth investigating.
ALLOGRAFT REJECTION
Although primary graft dysfunction is a phenomenon of innate immunity, allograft rejection has traditionally been thought to be exclusively within the domain of adaptive immunity. However, there is a strong association between primary graft dysfunction and chronic allograft rejection [62] and few studies have been done to link the two entities. In one line of investigation, experimental depletion of monocytes in murine models of heart and kidney transplantation was shown to blunt T-cell-mediated rejection [63] . In another study of murine lung transplant, CD4 þ T cells isolated from allogeneic lung recipients lacking circulating classical monocytes were protected against allorecognition, but allografts still experienced acute rejection [64] . Thus, evidence exists that monocytes and macrophages may link the innate and adaptive immune responses after transplantation, but further studies are necessary to fully elucidate these processes.
CONCLUSION
Monocytes and macrophages in the lung are crucial players in host innate immune defense against pathogens and processes of sterile inflammation involved in lung transplantation, including mechanical ventilation, ischemia-reperfusion, and primary graft dysfunction. A link between monocytes, macrophages, and allograft rejection likely exists and should be further characterized. Further studies are needed to elucidate the role of monocytes and macrophages in the pathogenesis of primary graft dysfunction and lung allograft rejection.
